CRIXIVAN (Merck Sharp & Dohme Corp.)
Welcome to the PulseAid listing for the CRIXIVAN drug offered from Merck Sharp & Dohme Corp.. This HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],Cytochrome P450 3A4 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Merck Sharp & Dohme Corp. |
| NON-PROPRIETARY NAME: | indinavir sulfate |
| SUBSTANCE NAME: | INDINAVIR SULFATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],Cytochrome P450 3A4 Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1996-03-13 |
| END MARKETING DATE: | 0000-00-00 |
CRIXIVAN HUMAN PRESCRIPTION DRUG Details:
| Item Description | CRIXIVAN from Merck Sharp & Dohme Corp. |
| LABELER NAME: | Merck Sharp & Dohme Corp. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 200(mg/1) |
| START MARKETING DATE: | 1996-03-13 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0006-0571_c257f3d4-d499-41fa-9161-1ec22456ab16 |
| PRODUCT NDC: | 0006-0571 |
| APPLICATION NUMBER: | NDA020685 |
Other INDINAVIR SULFATE Pharmaceutical Manufacturers / Labelers:
